Healthy men test new drug dosing in Early-Stage trial
NCT ID NCT07166783
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This completed Phase 1 study looked at how a single 7.5mg dose of tolvaptan is processed by the body in 10 healthy men aged 18-40. Researchers measured drug levels and safety, with no treatment for any disease involved. The goal was simply to gather data on the drug's behavior in healthy people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.